Link found between arthritis, liver disease and hemochromatosis


Thursday, 28 April, 2022

Link found between arthritis, liver disease and hemochromatosis

Researchers have identified a crucial link between arthritis and the risk of serious liver disease in people with Australia’s most common genetic condition.

An estimated 100,000 Australians carry the high-risk genotype for hemochromatosis, a condition affecting people of northern European descent which sees the body accumulate too much iron. It can lead to many complications — one of the most serious being advanced hepatic fibrosis, which affects the liver and can lead to cirrhosis and liver cancer.

The good news is that early detection of advanced hepatic fibrosis can assist clinicians in identifying those most at risk and reducing the impact or occurrence of future complications. Now, Edith Cowan University (ECU) researchers collaborating with colleagues at the QIMR Berghofer Institute for Medical Research have discovered arthritis is a strong predictor for development of clinically important liver problems in people with hemochromatosis.

The researchers studied 112 people with hemochromatosis. Of the 19 people with advanced stage 3–4 liver fibrosis, 84% also had arthritis. Meanwhile, of the 65 subjects without arthritis, only 5% had advanced hepatic fibrosis. The results were published in the journal Mayo Clinic Proceedings.

ECU Professor John Olynyk, the senior author on the study, said the results have many implications for those either living with hemochromatosis or at risk of developing it.

“Since hepatic fibrosis improves with treatment, it is important to accurately determine the presence or absence of advanced hepatic fibrosis when patients are evaluated,” he said.

“We recommend people with hemochromatosis who present with arthritis be properly evaluated for the presence of advanced hepatic fibrosis.”

Olynyk said the study could also save many people from undergoing unnecessary procedures. He said, “Those with hemochromatosis, but who do not have arthritis at diagnosis, are highly unlikely to have advanced hepatic fibrosis, which may negate the need for an initial liver biopsy.

“Instead, they can be monitored for the development of fibrosis via non-invasive methods.”

Olynyk concluded that the link with arthritis could help diagnose more people with hemochromatosis, which can often be difficult due to many symptoms being relatively non-specific and common in the general population.

“People of the correct background presenting with arthritis or liver disease should always be evaluated for potential hemochromatosis — especially when it is not clear as why the problem exists,” he said.

Image credit: ©stock.adobe.com/au/chajamp

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

Phage therapy combo to combat antibiotic resistance

Using a combination of phages and antibiotics may be far more effective against bacterial...

Winter COVID boosters expanded, Burnet and Moderna partner on novel mRNA vaccines

The COVID-19 booster program will expand to further at-risk population groups from 30 May 2022.

Wireless neurostimulator like a pacemaker for the brain

Neurological disorders like Parkinson's, chronic depression and other psychiatric conditions...


  • All content Copyright © 2022 Westwick-Farrow Pty Ltd